Dianthus Therapeutics (DNTH) Receivables - Net (2022 - 2025)
Dianthus Therapeutics (DNTH) has 4 years of Receivables - Net data on record, last reported at $5.0 million in Q3 2025.
- For Q3 2025, Receivables - Net rose 259.71% year-over-year to $5.0 million; the TTM value through Sep 2025 reached $5.0 million, up 259.71%, while the annual FY2023 figure was $294000.0, 93.74% down from the prior year.
- Receivables - Net reached $5.0 million in Q3 2025 per DNTH's latest filing, up from $39000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $5.0 million in Q3 2025 and bottomed at $39000.0 in Q2 2025.
- Average Receivables - Net over 4 years is $1.5 million, with a median of $840000.0 recorded in 2024.
- Peak YoY movement for Receivables - Net: surged 499.14% in 2024, then plummeted 95.36% in 2025.
- A 4-year view of Receivables - Net shows it stood at $4.7 million in 2022, then tumbled by 93.74% to $294000.0 in 2023, then skyrocketed by 372.79% to $1.4 million in 2024, then surged by 259.71% to $5.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Net were $5.0 million in Q3 2025, $39000.0 in Q2 2025, and $1.0 million in Q1 2025.